# ZFP69

## Overview
ZFP69 is a gene that encodes the ZFP69 zinc finger protein, which is a member of the zinc finger protein family. These proteins are characterized by their ability to bind DNA and are often involved in transcriptional regulation. The ZFP69 protein is implicated in metabolic processes, particularly in the context of obesity and diabetes. It has been studied for its role in lipid metabolism and insulin sensitivity, with evidence suggesting that it may influence lipid deposition in the liver and adipose tissue. In mouse models, alterations in the ZFP69 gene have been associated with changes in susceptibility to diabetes, highlighting its potential impact on metabolic health (Scherneck2009Positional). The human orthologue, ZNF642, has been linked to type 2 diabetes, further underscoring the gene's relevance in metabolic disorders (Schwenk2013Genetic; Scherneck2009Positional).

## Clinical Significance
The ZFP69 gene is implicated in the pathogenesis of obesity-associated diabetes. In certain mouse models, the disruption of Zfp69 by a retroviral transposon leads to a truncated mRNA and a loss-of-function variant, which is associated with reduced susceptibility to diabetes. Conversely, the presence of the normal allele enhances hyperglycemia in obese mice, suggesting that ZFP69 plays a role in promoting lipid deposition in the liver and affecting lipid storage in adipose tissue (Scherneck2009Positional).

In humans, the orthologue ZNF642 shows increased expression in the adipose tissue of individuals with type 2 diabetes, indicating a similar role in diabetes pathogenesis (Schwenk2013Genetic; Scherneck2009Positional). Overexpression of Zfp69 in transgenic mice has been shown to impair insulin sensitivity, increase liver fat, and elevate plasma triacylglycerol levels, contributing to insulin resistance (Chung2015The). These findings suggest that ZFP69 may interact with other genetic variants to exacerbate diabetes-related phenotypes, such as hyperglycemia and beta cell failure, highlighting its potential clinical significance in understanding and targeting obesity-related diabetes (Chung2015The; Scherneck2009Positional).


## References


[1. (Schwenk2013Genetic) Robert Wolfgang Schwenk, Heike Vogel, and Annette Schürmann. Genetic and epigenetic control of metabolic health. Molecular Metabolism, 2(4):337–347, November 2013. URL: http://dx.doi.org/10.1016/j.molmet.2013.09.002, doi:10.1016/j.molmet.2013.09.002. This article has 108 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.molmet.2013.09.002)

[2. (Chung2015The) Bomee Chung, Mandy Stadion, Nadja Schulz, Deepak Jain, Stephan Scherneck, Hans-Georg Joost, and Annette Schürmann. The diabetes gene zfp69 modulates hepatic insulin sensitivity in mice. Diabetologia, 58(10):2403–2413, August 2015. URL: http://dx.doi.org/10.1007/s00125-015-3703-8, doi:10.1007/s00125-015-3703-8. This article has 18 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1007/s00125-015-3703-8)

[3. (Scherneck2009Positional) Stephan Scherneck, Matthias Nestler, Heike Vogel, Matthias Blüher, Marcel-Dominique Block, Mauricio Berriel Diaz, Stephan Herzig, Nadja Schulz, Marko Teichert, Sina Tischer, Hadi Al-Hasani, Reinhart Kluge, Annette Schürmann, and Hans-Georg Joost. Positional cloning of zinc finger domain transcription factor zfp69, a candidate gene for obesity-associated diabetes contributed by mouse locus nidd/sjl. PLoS Genetics, 5(7):e1000541, July 2009. URL: http://dx.doi.org/10.1371/journal.pgen.1000541, doi:10.1371/journal.pgen.1000541. This article has 65 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1371/journal.pgen.1000541)